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1. Introduction 
Studies with a variety of synthetic double-stranded 
polynucleotides have shown that induction of in- 
terferon and resistance to viral infection depends on 
a) a sufficiently high molecular weight [l-3] , b) 
thermal stability (T,) [4] , c) resistance to nuclease 
degradation [S, 61 and d) the presence of ribose as 
the carbohydrate moiety [7, 81, testified to by the 
relative inactivity of double-stranded DNA and RNA- 
DNA hybrids as compared to double-stranded RNA 
[7-91. Studies on the antiviral activity of 2’-O-methyl- 
ated and 5methylated polynucleotides are presented 
in this report. These studies were aimed at delineating 
the effects of methylation of the heterocyclic ring and 
the ribose 2’-OH, and of the associated changes in 
thermal stability, on antiviral activity. 
2. Materials and methods 
Poly (rI), SzO 9.1 and poly (rC), SzO - 6.0 were 
products of P.-L. Biochemicals (Milwaukee, Wise., 
USA); poly (rA), Sz e 9.2 and poly (rU), SzO 3.5 were 
obtained from Miles Laboratories (Elkhart, Indiana); 
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and poly (dc), $0 - 6.0 from Biopolymers (Pine- 
brook, New Jersey). The remaining polymers were 
synthesized according to published procedures: poly 
(2’-OMeC)t , S2e 9.0 [lo] ; poly (2’-OMeU), Szo 
9.0 [ 1 l] ; poly (5MerC), Sse 3.4 [ 121 ; poly (5 
MedC), SzO 7.6 [ 131. Sedimentation constants, and 
melting profiles and T, values (see also fig. 1) were 
obtained as described elsewhere [ 131. 
Antiviral activity of polynucleotides was assessed 
by measurement of VSV plaque inhibition in PRK cell 
cultures in 50-mm Falcon plastic Petri dishes. Serial 
(1 to 10) dilutions of the polymers were prepared in 
MEM (minimal Eagle’s medium) and incubated on 
the cells (4 ml/Petri dish) for 20 hr at 37”. The super- 
natant was then removed and the cells challenged 
with VSV. Virus plaques were counted 2 days later. 
Since previous trials demonstrated that the full activ- 
ity of poly (rI)-poly (rC) may be attained, and even 
surpassed, when the homopolymer components are 
added sequentially [ 17,181, experiments were con- 
ducted both with preformed complexes and by se- 
quential administration of the two somponents. 
Complexes were tested at concentrations from 1 O-’ 
to 10 pg/ml. When tested sequentially, the first poly- 
nucleotide was applied to the cells at 10 pg/ml for 
1 hr; the cells were then washed 3 times and further 
$ Abbreviations: Poly (2’-OMeC), poly 2’-0-methylcytidylic 
acid; poly (2’-OMeU), poly 2’-0-methyluridylic acid; poly 
(S-MerC), poly 5-methylribocytidylic acid; poly (S-MedC), 
poly S-methyldeoxycytidylic acid; VSV, vesicular stomatitis 
virus; PRK, primary rabbit kidney. 
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Fig. 1. Melting profiles, in 0.15 M NaCl at pH 7.8, of com- 
plexes of poly (11) (---_) with: 1) poly (0, Tm 64” [ 121, 
2) poly (dC), T,,, 55” [ 141, 3) poly (2’-OMeC), T,,, 61.5” 
[ 15],4) poly (5-MerC), T, 80.5” [ 121, 5) poly (5-MedC), 
T,,,,, 65” ; and of complexes of poly (rA) (- - - -1 with : 6) poly 
(IV), T,,, 59” [ 11,161, 7) poly (2’-OMeU), T, 70.5 [ 111. 
Melting profiles 2), 6) and 7) have been recalculated from 
the original papers for a salt concentration of 0.15 M. 
incubated with concentrations of lo-’ to 10 pg/ml 
of the second polymer prior to virus challenge. 
3. Results 
It was previously shown [ 1 O-l 21 that, under the 
conditions herein employed for antiviral activity 
tests, double-stranded complexes are formed by poly 
(2’-OMeC) or poly (5MerC) with poly (rl), and by 
poly (2’-OMeU) with poly (rA). The melting profiles 
for these complexes in 0.15 M NaCl are shown in fig. 1. 
To establish the nature of the complex between poly 
(rl) and poly (S-MedC), 1 : 1 and 2 : 1 mixtures were 
prepared in various NaCl concentrations from 0.02 to 
0.5 M. Observed hyperchromicities during melting 
were 62% and 32% respectively (fig. 2) testifying 
[ 131 to formation of the double-stranded hybrid poly 
(rl)-poly (5MedC), irrespective of the ratio of the 
two components. In 2 : 1 mixtures of poly (rl) and 
poly @MedC), the lower hyperchromicity during 
melting is due to the fact that 50% of the poly (rl) 
component is free. At higher salt concentrations 
(0.5 M), the free poly (rl) forms its own helical struc- 
ture, the melting of which is responsible for a small 
Fig. 2. Melting profiles, in 0.01 M phosphate buffer pH 7,8, 
for mixtures of poly (r1) and poly (5-MedC) in molar ratios 
of 1 : 1 (left) and 2 : 1 (right). Individual profiles in each fig- 
ure are for NaCl concentrations of 0.02, 0.05, 0.11, 0.20 and 
0.50 M (from left to right). Insert shows dependence of T, 
on Na+ concentration for poly (rI)-poly (5-MedC). 
increase in absorption up to 60”, as well as for an ap- 
preciable change in profile in 0.5 M NaCl (fig. 2, 
right-hand diagram). The insert to fig. 2 exhibits the 
T, dependence of poly (rl)-poly (5-MedC) on salt 
concentration. 
Antiviral activities are presented in table 1; the 
data obtained with poly (rl)-poly (rC), poly (rA)- 
poly (rU) and poly (rI)-poly (dC) are in accord with 
data reported in earlier studies [7,8, 17-191. 
It will be noted that methylation of the 2’-OH in 
poly (I-C) and poly (rU) led to a drastic decrease in 
activity of the respective complexes with poly (rl) 
and poly (rA). Analogous results were obtained when 
the homopolymers were adminstered sequentially. 
In contrast, replacement of poly (rC) by poly (5- 
MerC) did not markedly affect the activity of the 
complex with poly (rl). Sequential administration in 
the order poly (rI), poly (5-MerC) also yielded the 
same activity as the preformed complex, whereas 
administration in the reverse order led to consider- 
ably lower activiry, a finding only in qualitative agree- 
ment with results for sequential adminstration of poly 
(rl) and poly (rC) [ 171 This failure of poly (5-MerC) 
to effectively “prime” the cells for antiviral activity 
of poly (rl) may conceivably be due to the lower mole- 
cular weight of the former (SzO 3.4) as compared to 
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Table 1 





Minimum inhibitory concentration* (pg/ml) 
Poly no. 1 Poly no. 1, then Poly no. 2, then 
complexed poly no. 2 in poly no. 1 in 
to poly no. 2 1 hr 1 hr 
Poly rI Poly rc 0.0004 0.00004 0.0004 
Poly rA Poly rU 0.04 > 10 > 10 
Poly rI Poly 2’-0-MeC 4 > 10 4-10 
Poly rA Poly 2’-0-MeU > 10 > 10 > 10 
Poly rI Poly S-MerC 0.001 0.0004 1 
Poly rl Poly dC > 10 2 10 > IO 
Poly r1 Poly S-MedC > 10 > 10 10 
* Concentration of polymer (either the polynucleotide complex, or polynucleotide no. 2, if polynucleotide no. 2 is added second, 
or polynucleotide no. 1, if polynucleotide no. 1 is added second) required to reduce VSV plaque formation by 50%. 
~01~ (0 (S20 - 6); it should be recalled that a mini- 
mum Sze value of 3.2 established as necessary for 
maximum antivital activity applies only to preformed 
complexes [ l--3] . 
Finally, it will be observed that neither poly (rI)- 
poly (dC), nor poly (rI)-poly (5MedC), exhibited 
significant activity even at 10 I*g/ml. Only slight activ- 
ity was noted on administration of poly (5-MedC), 
followed by poly (rI), but not when they were given 
in the reverse order (table 1). 
4. Discussion 
The inactivity of poly (dC) as compared to poly 
(rC), and of poly (5-MedC) relative to poly (5MerC), 
could be due to differences in conformation between 
the ribose and deoxyribose moieties, or to the pres- 
ence of 2’-OH in the ribose residues. The negligible 
activities of poly (2’-OMeC) and poly (2’-OMeU) are 
rather surprising since their complexes with poly (rI) 
and poly (rA), respectively, exhibit physico-chemical 
properties similar to those of the correspondence ribo, 
but not deoxyribo, polymers [ 15,16,20] . The 2’0 
methyl complexes fulfil the general requirements [l-6] 
for antiviral activity and interferon induction, viz. a) 
sufficiently high molecular weight (cf. Materials and 
methods); b) high thermal stability (figs. 1 and 2); c) 
absolute resistance to pancreatic ribonuclease and low 
susceptibility to other nucleases [ 10,111. It therefore 
appears that the presence of the 2’-OH is a prerequisite 
for interferon induction activity, an inference further 
supported by the loss of activity of poly (rC) on re- 
placement by poly (2’~O-acetyl C) [2 l] or by poly 
(2’-deoxy-2’-chloro C) [22,23]. Furthermore, although 
poly (rI)-poly (rC) resembles poly (rI)-poly (dC) 
physico-chemically, as shown by similarity of X-ray 
diffraction patterns [24] and lack of formation of 
triple-stranded complexes with poly (r1) [ 141, they 
differ considerably in antiviral activity (table 1 and 
[7,8] ). Finally, it may not be without relevance that 
both poly (2’-OMeC) and poly (2’-OMeU) are inactive 
as in vitro messengers [25]. 
It is of additional interest that, notwithstanding 
the higher thermostability (16.5”) of poly (rI)-poly 
(5-MerC) relative to poly (rI)-poly (rC) (fig. l), 
(although both complexes exhibit similar conforma- 
tions [ 121) the former does not exhibit an increased 
antiviral activity (table 1). Fig. 1 also shows that poly 
(rI)-poly (5-MedC) melts at a T, 10’ higher than 
poly (rI)-poly (dC); both complexes exhibit similar 
conformations, but the former is as inactive as the lat- 
ter (table 1). From these results it can be concluded 
that neither the presence of the 5-methyl substituent, 
nor the associated increased thermal stability, influ- 
ence the biological activity. 
Acknowledgements 
We are indebted to Prof. P. De Somer for con- 
tinuous interest and support, to Dr. M. Joniau and 
139 
Volume 24, number 1 FEBS LETTERS July 1972 
Dr. K. Heremans for help with the spectral absorption 
and thermal stability measurements, and to Mrs. A. 
Van Lierde and Mrs. E. Poddany for excellent techni- 
cal assistance. This work was supported, in part, by 
the Belgian “Fonds voor Geneeskundig Wetenschap- 
pelijk Onderzoek” (F.G.W.O.), the Polish Academy 
of Sciences (Project 09.3.1.) and also profited from 
the support of the Wellcome Trust and the World 
Health Organization. 
References 
[l] G.P. Lampson, A.K. Field, A.A. Tytell, M.M. Nemes 
and M.R. Hilleman, Proc. Sot. Exp. Biol. Med. 135 
(1970) 911. 
[2] A.A. Tytell, G.P. Lampson, A.K. Field, M.M. Nemes 
and M.R. Hilleman, Proc. Sot. Exp. Biol. Med. 135 
(1970) 917. 
[ 31 J.F. Niblack and M.B. McCreary, Nature New Biol. 233 
(1971) 52. 
[4] E. De Clercq and T.C. Merigan, Nature 222 (1969) 1148. 
[5] E. De Clercq, F. Eckstein, H. Sternbach and T.C. Meri- 
gan, Virology 42 (1970) 421. 
[6] E. De Clercq, R.D. Wells, R.C. Grant and T.C. Merigan, 
J. Mol. Biol. (1971) 83. 
[ 71 I. Vilcek, M.H.Ng, A.E. Friedman-Kien and T. Krawciw, 
J. Virol. 2 (1968) 648. 
(81 C. Colby and M.J. Chamberlin, Proc. Natl. Acad. Sci. 
U.S. 63 (1969) 160. 
[9] C. Colby, B.D. Stollar and M.I. Simon, Nature New Biol. 
229 (1971) 172. 
[IO] C. Janion, B. Zmudzka and D. Shugar, Acta Biochim. 
Polon. 17 (1970) 31. 
[ 1 l] B. Zmudzka and D. Shugar, Acta Biochim. Polon. 18 
(1971) 321. 
[ 121 W. Szer and D. Shugar, J. Mol. Biol. 17 (1966) 174. 
[ 131 B. Zmudzka, F.J. Bollum and D. Shugar, Biochemistry 8 
(1969) 3049. 
[ 141 M.J. Chamberlin and D.L. Patterson, J. Mol. Biol. I2 
(1965,410. 
[ 151 B. Zmudzka, M. Tichy and D. Shugar, Acta Biochim. Polon. 
(1972) in press. 
[ 161 B. Zmudzkd and D. Shugar, FEBS Letters 8 (1970) 52. 
(171 E. De Clercq and P. De Somer, Science 173 (1971) 260. 
[ 181 E. De Clercq and P. De Somer, J. Virol. (1972) in press. 
[19] A.K. I:ield, A.A. Tytell, G.P. Lampson and M.R. Hille- 
mar], Proc. Natl. Acad. Sci. U.S. 61 (1968) 340. 
[ 201 B. Zmudzka, C. Janion and D. Shugar, Biochem. Bio- 
phys. Res. Commun. 37 (1969) 895. 
[21] D.L. Steward, W.C. Herndon, Jr. and K.R. Schell, Bio- 





J. Hobbs, H. Sternbach and F. Eckstein, F’EBS Letters 
15 (1971) 345. 
D.R. Black, F. Eckstein, J. Hobbs, H. Sternbach and 
T.C. Meripan, personal communication ( 197 1). 
D.R. Davies, Nature 186 (1960) 1030. 
BE. Dunlap, K.H. Friderici and F. Rottman, Bio- 
chemistry 10 (1971) 2581. 
140 
